Nplate 500 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHNW0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,034
Award facts
- Contract value 100% obligated
- $16,033.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 500 microgram vials of Nplate, valued at $16,033.72 under firm fixed-price terms. The delivery order was awarded on January 28, 2026, with an ultimate completion date of February 19, 2026, and represents a non-set-aside procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply chain support to Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal defense medical system through consistent performance on numerous delivery orders spanning diverse therapeutic categories. The company's PPV-G GEN V contract, awarded in November 2025 with a $500 million ceiling and completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support recurring medical supply requirements across the global military healthcare network. The current Nplate delivery order reflects the company's ongoing fulfillment of specialized pharmaceutical needs within this comprehensive prime vendor framework.
Quick answers
Who was awarded contract SPE2DR26FHNW0?
SPE2DR26FHNW0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FHNW0 worth?
The government has obligated $16,034 on SPE2DR26FHNW0.
Is contract SPE2DR26FHNW0 an order under another contract?
Yes. SPE2DR26FHNW0 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNW0 competed?
The extent of competition for SPE2DR26FHNW0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award